Flagship Pioneering, Samsung Partner on Translational Science

Will leverage technology, AI, and CDMO services across Flagship's ecosystem of companies.

Flagship Pioneering, a bioplatform innovation company, and Samsung, have partnered to foster biopharmaceutical innovation through advancements in translational science and medicine. Samsung will work alongside Flagship-founded companies leveraging its technologies and capabilities to accelerate first and best-in-class therapies. The strategic partnership expands upon an ongoing cooperation between Samsung and Flagship and leverages the expertise of both organizations in the areas of life scie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters